Key risks
- Operational continuity unproven: company generated near-zero revenue from mid-2023 through Q4 FY24, then rebounded sharply. Verify whether restart is durable or driven by temporary demand.
- Thin margins persist even in recovery phase: best OPM of 9.01% (Dec 2024) declines to 7.29% (Mar 2025) and 3.96% (Sep 2024), compressing profit on even small cost shocks.
- Valuation disconnect: PE of 25.68 prices in growth the early-stage restart has not yet proven; stock fell 22% over 12 months despite operational recovery.
- Zero institutional participation (FII/DII = 0%) signals limited confidence from professional investors despite promoter majority holding.
Generated analysis · source review pending